Trial · NCT07882069
Effect of ACTIVE-Care on Cancer-Related Fatigue, Hope, and Psychological Resilience in Adolescents With Acute Lymphoblastic Leukemia
NCT07882069, Not applicable, Completed, Selcuk University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effect of ACTIVE-Care on Cancer-Related Fatigue, Hope, and Psychological Resilience in Adolescents With Acute Lymphoblastic Leukemia. Trials, record NCT07882069. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07882069
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effect of ACTIVE-Care on Cancer-Related Fatigue, Hope, and Psychological Resilience in Adolescents With Acute Lymphoblastic Leukemia
- NCT number
- NCT07882069
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 70 participants, actual
- Lead sponsor
- Selcuk University
- Conditions
- Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Adolescent, Resilience, Psychological, Physical Activities
- Interventions
- ACTIVE-Care Integrated Physical Activity-Based Supportive Care Program
- First posted
- 2026-10-20
- Last updated
- 2026-10-20
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Cancer-Related Fatigue - Assessment Scale for Fatigue in Pediatric Oncology Patients Aged 13-18 Years | Baseline (within 1 week before the intervention) and immediately after the 6-week intervention | Cancer-related fatigue is assessed using the Assessment Scale for Fatigue in Pediatric Oncology Patients Aged 13-18 Years. Total scores range from 32 to 160, with higher scores indicating lower fatigue and a better outcome, and lower scores indicating greater fatigue and a worse outcome. Change in total score is evaluated from baseline to immediately after the six-week intervention. |
| Primary | Change in Hope - Children's Hope Scale (CHS) | Baseline (within 1 week before the intervention) and immediately after the 6-week intervention | Hope is assessed using the Children's Hope Scale, a six-item measure with each item rated from 1 to 6. Total scores range from 6 to 36, with higher scores indicating greater hope and a better outcome. Change in total score is evaluated from baseline to immediately after the six-week intervention. |
| Primary | Change in Psychological Resilience - Child and Youth Resilience Measure-12 (CYRM-12) | Baseline (within 1 week before the intervention) and immediately after the 6-week intervention | Psychological resilience is assessed using the Child and Youth Resilience Measure-12, a 12-item measure with each item rated from 1 to 5. Total scores range from 12 to 60, with higher scores indicating greater psychological resilience and a better outcome. Change in total score is evaluated from baseline to immediately after the six-week intervention. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07882069
GET https://conductscience.org/api/trials/v1/NCT07882069/registered